Suchergebnisse - "Xu, Xiaowei"

PubPharm (20)

1

Autophagy Paradox : Strategizing Treatment Modality in Melanoma

enthalten in: Current treatment options in oncology | 2023

von Pangilinan, C. | Xu, X. | Herlyn, M. | +1

2

Structure-Based Discovery of Potent CARM1 Inhibitors for Solid Tumor and Cancer Immunology Therapy

enthalten in: Journal of medicinal chemistry | 2021

von Zhang, Z. | Guo, Z. | Xu, X. | +15

3

Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance

enthalten in: Cancer research | 2021

von Liu, J. | Rebecca, V. | Kossenkov, A. | +45

4

NRAS Q61R and BRAF G466A mutations in atypical melanocytic lesions newly arising in advanced melanoma patients treated with vemurafenib

enthalten in: Journal of cutaneous pathology | 2019

von Parekh, V. | Sobanko, J. | Miller, C. | +11

5

ALDH1 Bio-activates Nifuroxazide to Eradicate ALDHHigh Melanoma-Initiating Cells

enthalten in: Cell chemical biology | 2018

von Sarvi, S. | Crispin, R. | Lu, Y. | +17

CommentIn: Cell Chem Biol. 2018 Dec 20;25(12):1439-1440. - PMID 30576659

6

Piribedil disrupts the MLL1-WDR5 interaction and sensitizes MLL-rearranged acute myeloid leukemia (AML) to doxorubicin-induced apoptosis

enthalten in: Cancer letters | 2018

von Zhang, X. | Zheng, X. | Yang, H. | +10

7

A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles

enthalten in: Cancer discovery | 2017

von Rebecca, V. | Nicastri, M. | McLaughlin, N. | +29

CommentIn: Cancer Discov. 2017 Nov;7(11):1218-1220. - PMID 29097619

8

Tumor-associated B-cells induce tumor heterogeneity and therapy resistance

enthalten in: Nature communications | 2017

von Somasundaram, R. | Zhang, G. | Fukunaga-Kalabis, M. | +50

9

JD enhances the anti-tumour effects of low-dose paclitaxel on gastric cancer MKN45 cells both in vitro and in vivo

enthalten in: Cancer chemotherapy and pharmacology | 2016

von Wang, C. | Wang, R. | Zhou, K. | +12

10

HSP70 Inhibition Limits FAK-Dependent Invasion and Enhances the Response to Melanoma Treatment with BRAF Inhibitors

enthalten in: Cancer research | 2016

von Budina-Kolomets, A. | Webster, M. | Leu, J. | +17